THERAPEUTIC COMPOSITIONS AND METHODS FOR TREATING DISEASE STATES WITH MUTANT FORMS OF MYELOID PROGENITOR INHIBITORY FACTOR-2 (MPIF-2) - Patent 1230264

(19)

(11)

EP 1 230 264 A1

(12)

(43)	Date of publication:
	14.08.2002 Bulletin 2002/33

(21)	Application number: 00975359.1

(22)	Date of filing: 25.10.2000

(51)	International Patent Classification (IPC)⁷: C07K 14/435, C07K 14/52

(86)	International application number:
	PCT/US0029/351

(87)	International publication number:
	WO 0130/828 (03.05.2001 Gazette 2001/18)

(84)	Designated Contracting States:
	AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
	Designated Extension States:
	AL LT LV MK RO SI

(30)

Priority:

25.10.1999 US 161400 P

(71)	Applicant: HUMAN GENOME SCIENCES, INC.
	Rockville, MD 20850-3338 (US)

(72)	Inventors:
	GRZEGORZEWSKI, Krzysztof, J. Montgomery Village, MD 20879 (US) SALCEDO, Theodora, W. Gaithersburg, MD 20886 (US) KREIDER, Brent, L. Bedford, MA 01730 (US)

(74)	Representative: VOSSIUS & PARTNER
	Postfach 86 07 67 81634 München 81634 München (DE)

(54)	THERAPEUTIC COMPOSITIONS AND METHODS FOR TREATING DISEASE STATES WITH MUTANT FORMS OF MYELOID PROGENITOR INHIBITORY FACTOR-2 (MPIF-2)